AcuraStem logo

AcuraStem

Patient-Based Therapeutics

25 employees · est. 2016 · Pasadena, United States

VS
ProMIS™ Neurosciences, Inc. logo

ProMIS™ Neurosciences, Inc.

Precision therapeutics for protein misfolding disorders, including Alzheimer's, ALS and Parkinson’s disease.

22 employees · est. 2015 · Cambridge, United States

ProMIS™ Neurosciences, Inc. is the older company (2016 vs 2015).

Side-by-Side Comparison

AcuraStem ProMIS™ Neurosciences, Inc.
Founded
2016 2015 older
Headquarters
Pasadena, United States Cambridge, United States
Employees
25 22
Industry
AI, Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Grant Unknown
Total Funding
$12.00M $233.31M
Funding Rounds
4 17
Services
Not tracked yet Selective Antibody Therapy Development, Protein Folding Prediction, Clinical Research and Trials
Target Customers
Not tracked yet Healthcare Providers, Pharmaceutical Companies, Neuroscientific Research Institutions
Taxonomy
Not tracked yet Neuroscience, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Multiple System Atrophy, Treatment Development, Antibody Discovery, Misfolded Proteins, Disease-modifying Treatments
Website
acurastem.com promisneurosciences.com
AcuraStem logo

About AcuraStem

AcuraStem (acurastem.com) is a patient-based, drug development company pioneering drug discovery and ultimately how treatments are developed for neurodegenerative diseases—including sporadic ALS and FTD. Enabled by our ground-breaking iNeuroRx® technology platform - AcuraStem has discovered and is...

ProMIS™ Neurosciences, Inc. logo

About ProMIS™ Neurosciences, Inc.

ProMIS™ Neurosciences, Inc., founded in 2015 and headquartered in Canada, is a pioneering entity within the Biotechnology and Health Care sectors. The company is committed to developing next-generation, disease-modifying treatments specifically targeting Alzheimer’s disease, amyotrophic lateral scle...

We will tell you when either one moves

BounceWatch watches AcuraStem and ProMIS™ Neurosciences, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at AcuraStem and ProMIS™ Neurosciences,... — by email.

Frequently Asked Questions

AcuraStem — Patient-Based Therapeutics. ProMIS™ Neurosciences, Inc. — Precision therapeutics for protein misfolding disorders, including Alzheimer's, ALS and Parkinson’s disease.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
AcuraStem has raised $12.00M while ProMIS™ Neurosciences, Inc. has raised $233.31M.
AcuraStem and ProMIS™ Neurosciences, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare AcuraStem with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AcuraStem on 13 Sep 2024, and ProMIS™ Neurosciences, Inc. on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes